CN1240425C - Chinese traditional medicine for treating bone fracture and osteopathy - Google Patents
Chinese traditional medicine for treating bone fracture and osteopathy Download PDFInfo
- Publication number
- CN1240425C CN1240425C CNB2003101158921A CN200310115892A CN1240425C CN 1240425 C CN1240425 C CN 1240425C CN B2003101158921 A CNB2003101158921 A CN B2003101158921A CN 200310115892 A CN200310115892 A CN 200310115892A CN 1240425 C CN1240425 C CN 1240425C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- examples
- medicinal preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a Chinese medicinal preparation for treating fracture and osteopathy, which comprises pure Chinese medicines such as Chinese angelica, chuanxiong rhizome, tall gastrodis tuber, dragon blood, red sage root, tortoiseshell, ground beetle, liquorice root, notoginseng, prepared rehmannia root, musk, xihua or safflower, pangolin, ginseng, eucommia bark, twotoothed achyranthes root, dipsacus asper, rhizoma drynariae, dragon bone, pyritum, elder, vermilion, corydalis tuber, green tangerine peel, fructus aurantii, etc. The Chinese medicinal preparation is made into any known medicament form such as medicinal powder, pills (pellets), capsules, etc. and has the functions of joining the tendon and bone, strengthening the tendon and bone, promoting blood circulation to dissipate blood stasis, promoting the flow of qi by warming the channel, relieving rigidity of the muscle, dispersing the accumulation of pathogen, tonifying blood, promoting tissue regeneration, regulating the flow of qi, promoting the circulation of qi, alleviating pain, etc. The Chinese medicinal preparation has conspicuous and fast curative effects on fracture, prolapse (bulge) of lumbar intervertebral disc, cervical spondylosis, etc.; the Chinese medicinal preparation has certain curative effects on hyperostosis and other kinds of osteopathy. The Chinese medicinal preparation has the advantages of no toxic or side effect, convenient administration, etc.
Description
Technical field
The present invention relates to the field of Chinese medicines, is a kind of Chinese medicine preparation for the treatment of fracture, osteopathia.
Background technology
Fracture, orthopaedic diseases such as prolapse of lumbar intervertebral disc, cervical vertebra are the commonly encountered diseases of harm humans health, the Chinese medicine preparation of existing treatment treatment fracture, osteopathia is an example with GUZHE CUOSHANG JIAONANG, YAOTONGNING commonly used, still exists long, deficiency such as curative effect the is not good enough course of treatment.
Summary of the invention
The purpose of this invention is to provide a kind of evident in efficacy, instant effect, have no side effect, the treatment fracture of taking convenience, the Chinese medicine preparation of osteopathia.
Realize that the technical scheme that goal of the invention adopted is: a kind of treatment fracture, the Chinese medicine preparation of osteopathia is characterized in that the composition by weight that it comprises is: 15～30 parts of Radix Angelicae Sinensis, 20～30 parts of Rhizoma Chuanxiongs, 10～20 parts in Rhizoma Gastrodiae, 10～20 parts of Sanguis Draxonis, 20～35 parts of Radix Salviae Miltiorrhizaes, 10～20 parts of Carapax et Plastrum Testudiniss, 10～25 parts of Eupolyphaga Seu Steleophagas, 15～25 parts in Radix Glycyrrhizae, 10～20 parts of Radix Notoginseng, 15～30 parts of Radix Rehmanniae Preparata, 1～5 part in Moschus, 5～15 parts on Stigma Croci or Flos Carthami, 5～15 parts of Squama Manis, 20～30 parts of Radix Ginsengs, 15～25 parts of the Cortexs Eucommiae, 15～25 parts of Radix Achyranthis Bidentataes, 15～30 parts of Radix Dipsacis, 20～30 parts of Rhizoma Drynariae, 10～20 parts of Os Draconis, 5～15 parts of Pyritums, 15～25 parts of Ramulus Sambuci Williamsii, 3～10 parts in Cinnabaris, 15～30 parts of Rhizoma Corydalis, 10～20 parts on Pericarpium Citri Reticulatae Viride, 10～20 parts of Fructus Aurantiis.
The preferred weight component is: 20～25 parts of Radix Angelicae Sinensis, 23～28 parts of Rhizoma Chuanxiongs, 14～18 parts in Rhizoma Gastrodiae, 14～17 parts of Sanguis Draxonis, 25～30 parts of Radix Salviae Miltiorrhizaes, 13～16 parts of Carapax et Plastrum Testudiniss, 15～20 parts of Eupolyphaga Seu Steleophagas, 18～22 parts in Radix Glycyrrhizae, 14～18 parts of Radix Notoginseng, 20～25 parts of Radix Rehmanniae Preparata, 2～4 parts in Moschus, 8～12 parts on Stigma Croci or Flos Carthami, 8～12 parts of Squama Manis, 23～27 parts of Radix Ginsengs, 19～23 parts of the Cortexs Eucommiae, 17～21 parts of Radix Achyranthis Bidentataes, 20～25 parts of Radix Dipsacis, 22～26 parts of Rhizoma Drynariae, 14～18 parts of Os Draconis, 8～12 parts of Pyritums, 18～22 parts of Ramulus Sambuci Williamsii, 5～8 parts in Cinnabaris, 20～25 parts of Rhizoma Corydalis, 14～17 parts on Pericarpium Citri Reticulatae Viride, 14～17 parts of Fructus Aurantiis.
A kind of Chinese medicine preparation for the treatment of fracture, osteopathia of the present invention is prepared into any dosage forms such as known powder, ball (pellet) agent, capsule according to a conventional method.
A kind of Chinese medicine preparation for the treatment of fracture, osteopathia of the present invention is to adopt pure raw material of Chinese medicine, form through the science composition of prescription, have reunion of bone, bone and muscle strengthening, promoting blood circulation to remove blood stasis, promoting the flow of QI in the collateral by warming the meridian, Shujin eliminating stagnation, the tissue regeneration promoting that nourishes blood, regulate the flow of vital energy, effect such as circulation of qi promoting, pain relieving, and have evident in efficacy, instant effect, have no side effect, advantage such as taking convenience.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.The weight proportion for preparing each crude drug of embodiment 1-5 of Chinese medicine preparation of the present invention sees the following form.Weight unit price: kg
| Routine number | Radix Angelicae Sinensis | Rhizoma Chuanxiong | Rhizoma Gastrodiae | Sanguis Draxonis | Radix Salviae Miltiorrhizae |
| 1 | 15 | 20 | 10 | 10 | 20 |
| 2 | 20 | 23 | 14 | 14 | 25 |
| 3 | 23 | 25 | 15 | 15 | 27 |
| 4 | 25 | 28 | 18 | 17 | 30 |
| 5 | 30 | 30 | 20 | 20 | 35 |
| Routine number | Carapax et Plastrum Testudinis | Eupolyphaga Seu Steleophaga | Radix Glycyrrhizae | Radix Notoginseng | Radix Rehmanniae Preparata |
| 1 | 10 | 10 | 15 | 10 | 15 |
| 2 | 13 | 15 | 18 | 14 | 20 |
| 3 | 15 | 17 | 20 | 15 | 23 |
| 4 | 16 | 20 | 22 | 18 | 25 |
| 5 | 20 | 25 | 25 | 20 | 30 |
| Routine number | Moschus | Stigma Croci or Flos Carthami | Squama Manis | Radix Ginseng | The Cortex Eucommiae |
| 1 | 1 | 5 | 5 | 20 | 15 |
| 2 | 2 | 8 | 8 | 23 | 19 |
| 3 | 3 | 10 | 10 | 25 | 20 |
| 4 | 4 | 12 | 12 | 27 | 23 |
| 5 | 5 | 15 | 15 | 30 | 25 |
| Routine number | Radix Achyranthis Bidentatae | Radix Dipsaci | Rhizoma Drynariae | Os Draconis | Pyritum |
| 1 | 15 | 15 | 20 | 10 | 5 |
| 2 | 17 | 20 | 22 | 14 | 8 |
| 3 | 20 | 23 | 25 | 15 | 10 |
| 4 | 21 | 25 | 26 | 18 | 12 |
| 5 | 25 | 30 | 30 | 20 | 15 |
| Routine number | Ramulus Sambuci Williamsii | Cinnabaris | Rhizoma Corydalis | Pericarpium Citri Reticulatae Viride | Fructus Aurantii |
| 1 | 15 | 3 | 15 | 10 | 10 |
| 2 | 18 | 5 | 20 | 14 | 14 |
| 3 | 20 | 7 | 22 | 15 | 15 |
| 4 | 22 | 8 | 25 | 17 | 17 |
| 5 | 25 | 10 | 30 | 20 | 20 |
Each crude drug should meet version " Chinese pharmacopoeia prescription in 2000 among the embodiment.
Chinese medicine preparation of the present invention adopts the conventional method preparation, is technology well-known to those skilled in the art, its preparation method: (with embodiment 3 is example, and other embodiment is identical with embodiment 3).
Take by weighing each crude drug by embodiment 3 described weight proportions, make bottled pill through sterilization, pulverizing, drop pill (pellet), bottling, every bottled dose is 8g.Also can be with the crude drug after the sterilization, the encapsulated after crushed capsule of making, every capsules 0.5g.Sterilizing installation is for producing sterilization tank commonly used, the best Universalpulverizer that uses of disintegrating apparatus.
Chinese medicine preparation among the present invention can promote the healing of fracturing.Through more than 2 years, the clinical observation of 1/3 fracture patient down in the tibiofibula that the refractory of 86 examples is healed has obtained significant curative effect, and its acceptance rate is 90.70%.
1. clinical data: amount to case 86 examples, wherein male 50 examples, women 36 examples; The oldest 65 years old, minimum 15 years old, average 32 years old; The course of disease is the longest 3 days, the shortest 30 minutes, average 10 hours; Crush injury 32 examples, motor-vehicle accident injury 27 examples, get injured by a fall 21 examples, other reason 6 examples of causing injury; Belong to closed fracture 34 examples, open fracture 52 examples; Both cross-section shape 19 examples, oblique 35 examples, spiral type 18 examples are pulverized shape 14 examples.
2. Therapeutic Method and dose: after adopting operation and traditional method reduction, adopt different fixing meanss to fix according to the fracture concrete condition.For bottled ball (pellet) agent, every bottle of 8g, each oral 8g, every day 3 times (per 8 hours 1 time), 15 is a course of treatment; For capsule, every 0.5g, each oral 16, every day 3 times (per 8 hours 1 time), 15 is a course of treatment.During treating, take the photograph X-ray film, understand the growth of spur situation, have or not callus to judge the clinical healing time in conjunction with having a medical check-up.
3. efficacy evaluation:
1. criterion of therapeutical effect is formulated according to " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " of national Department of Health in 1994 issue.Excellent: as to shift to an earlier date 2 week or above persons than normal healing time; Very: shifted to an earlier date for 1 week than normal healing time; Can: the normal clinical union of bone time is 10 weeks both; Prolong than normal healing time, even fracture delayed union or disunion take place.
2. therapeutic effect: in 86 examples, excellent: 46 examples, good: 32 examples, can: 8 examples, poor: 0, acceptance rate 90.70%.
Chinese medicine preparation of the present invention, through more than 2 years, the clinical practice to 140 routine prolapse of lumbar intervertebral disc (bulging) diseases has obtained significant curative effect, its total effective rate 94.29%.
1. clinical data: amount to case 140 examples, wherein male 82 examples, women 58 examples; Age is less than 30 years old 15 example, 31-60 year 116 examples, greater than 60 years old 9 example; The single-unit section is given prominence to 125 examples, outstanding 15 examples of two segment; Both pleurapophysis type 119 examples, central projection removing from mould 21 examples; Two weeks of the course of disease are with interior 60 examples, two week～1 year 70 examples, 10 examples more than 1 year; Above case does not all have disc removal history of operation, suction art history, reaches the molten nuclear treatment of collagenase history, and all be diagnosed as prolapse of lumbar intervertebral disc, deviate from or bulging through CT or MRI inspection, all be primary symptom with the lumbago and skelalgia.
2. method of administration: take capsule, every 0.5g, each oral 8, every day 3 times (per 8 hours 1 time), 20 is a course of treatment.
3. efficacy evaluation:
1. criterion of therapeutical effect, cure: lumbago and skelalgia disappears, and straight lower limb is raised experiment more than 70 °, recovers former work; Take a turn for the better: lumbago and skelalgia alleviates, and the waist movable function improves; Do not heal: symptom, sign do not have improvement.
2. therapeutic effect: in 140 examples, cure 56 examples, 76 examples that take a turn for the better, 8 examples more, total effective rate 94.29%.
Chinese medicine of the present invention is controlled agent through more than 5 years, and the clinical practice to 316 routine cervical vertebra diseases has obtained significant curative effect, its total effective rate 97.78%.
1. clinical data: amount to case 316 examples, make a definite diagnosis in conjunction with clinical symptoms through CT or X-ray film.Wherein male 145 examples, women 171 examples; Age 23-57 year, average 34 years old; The course of disease is the shortest 1 month, the longest 19 years, average 40 months; Be divided into local type 79 examples, spondylotic radiculopathy 162 examples, vertebral artery type 39 examples, mixed type 31 examples, myeloid form 5 examples by traditional Chinese medical science disease diagnosis and treatment standard.
2. Therapeutic Method and dose: adopt the acupuncture partner treatment, get 4～6 caves such as wind pond, Jiaji, big vertebra, Jianjing, shoulder Wailing, Zhongfu, Quchi, Ah Ci cave, at every turn with acupuncture needle even reinforcing-reducing method or nerve trunk provocative maneuver acupuncture 1 time, let the acupuncture needle remain at a certain point 30 minutes, get row nape flesh functional exercise behind the pin; Oral capsule, every 0.5g, each oral 8, every day 3 times (per 8 hours 1 time), 15 is a course of treatment.
3. efficacy evaluation:
1. criterion of therapeutical effect, cure: original symptom complete obiteration, muscular strength is normal, and neck, limb functional recover are normal, can participate in operate as normal; Take a turn for the better: original neck shoulder back of the body sx, function is improved, and can take care of oneself and also can participate in labor in general; Do not heal: symptom, function all do not have improvement.
2. therapeutic effect: in 316 examples, through treat 2～3 courses of treatment, by the standard rating course of treatment, cure 238 examples, 71 examples that take a turn for the better, 7 examples more, total effective rate 97.78%.
Chinese medicine preparation of the present invention all has certain curative effect to treatment hyperosteogeny, other osteopathia.
Claims (2)
1. a treatment is fractured, the Chinese medicine preparation of osteopathia is characterized in that it is made by following medicaments in part by weight: 15～30 parts of Radix Angelicae Sinensis, 20～30 parts of Rhizoma Chuanxiongs, 10～20 parts in Rhizoma Gastrodiae, 10～20 parts of Sanguis Draxonis, 20～35 parts of Radix Salviae Miltiorrhizaes, 10～20 parts of Carapax et Plastrum Testudiniss, 10～25 parts of Eupolyphaga Seu Steleophagas, 15～25 parts in Radix Glycyrrhizae, 10～20 parts of Radix Notoginseng, 15～30 parts of Radix Rehmanniae Preparata, 1～5 part in Moschus, 5～15 parts on Stigma Croci or Flos Carthami, 5～15 parts of Squama Manis, 20～30 parts of Radix Ginsengs, 15～25 parts of the Cortexs Eucommiae, 15～25 parts of Radix Achyranthis Bidentataes, 15～30 parts of Radix Dipsacis, 20～30 parts of Rhizoma Drynariae, 10～20 parts of Os Draconis, 5～15 parts of Pyritums, 15～25 parts of Ramulus Sambuci Williamsii, 3～10 parts in Cinnabaris, 15～30 parts of Rhizoma Corydalis, 10～20 parts on Pericarpium Citri Reticulatae Viride, 10～20 parts of Fructus Aurantiis.
2. a kind of treatment fracture according to claim 1, the Chinese medicine preparation of osteopathia is characterized in that it is made by following medicaments in part by weight: 20～25 parts of Radix Angelicae Sinensis, 23～28 parts of Rhizoma Chuanxiongs, 14～18 parts in Rhizoma Gastrodiae, 14～17 parts of Sanguis Draxonis, 25～30 parts of Radix Salviae Miltiorrhizaes, 13～16 parts of Carapax et Plastrum Testudiniss, 15～20 parts of Eupolyphaga Seu Steleophagas, 18～22 parts in Radix Glycyrrhizae, 14～18 parts of Radix Notoginseng, 20～25 parts of Radix Rehmanniae Preparata, 2～4 parts in Moschus, 8～12 parts on Stigma Croci or Flos Carthami, 8～12 parts of Squama Manis, 23～27 parts of Radix Ginsengs, 19～23 parts of the Cortexs Eucommiae, 17～21 parts of Radix Achyranthis Bidentataes, 20～25 parts of Radix Dipsacis, 22～26 parts of Rhizoma Drynariae, 14～18 parts of Os Draconis, 8～12 parts of Pyritums, 18～22 parts of Ramulus Sambuci Williamsii, 5～8 parts in Cinnabaris, 20～25 parts of Rhizoma Corydalis, 14～17 parts on Pericarpium Citri Reticulatae Viride, 14～17 parts of Fructus Aurantiis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101158921A CN1240425C (en) | 2003-12-02 | 2003-12-02 | Chinese traditional medicine for treating bone fracture and osteopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101158921A CN1240425C (en) | 2003-12-02 | 2003-12-02 | Chinese traditional medicine for treating bone fracture and osteopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1546123A CN1546123A (en) | 2004-11-17 |
| CN1240425C true CN1240425C (en) | 2006-02-08 |
Family
ID=34337432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101158921A Expired - Fee Related CN1240425C (en) | 2003-12-02 | 2003-12-02 | Chinese traditional medicine for treating bone fracture and osteopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1240425C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101518627B (en) * | 2009-04-08 | 2011-06-15 | 苏玉林 | Drug for treating broken bones by fast reunion of muscles and bones |
| CN102526506B (en) * | 2012-01-09 | 2013-10-09 | 郭华 | Medicament for treating osteopathia |
| CN104352610A (en) * | 2014-10-21 | 2015-02-18 | 苏州仁捷瑞自动化科技有限公司 | Recipe for bone setting plaster and preparation method for bone setting plaster |
| CN104352956A (en) * | 2014-10-21 | 2015-02-18 | 苏州仁捷瑞自动化科技有限公司 | Quick-acting bonesetting ointment patch and preparation method thereof |
| CN106138262A (en) * | 2015-04-14 | 2016-11-23 | 张波 | The medicine for the treatment of fracture |
| CN106074850A (en) * | 2016-07-28 | 2016-11-09 | 马荣春 | A kind of bone-setting medicament and preparation method thereof of invigorating blood circulation handed down from one's ancestors |
| CN106237185A (en) * | 2016-08-16 | 2016-12-21 | 李向松 | A kind of Chinese medicine treating prolapse of lumbar intervertebral disc |
-
2003
- 2003-12-02 CN CNB2003101158921A patent/CN1240425C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1546123A (en) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101623415B (en) | Traditional Chinese medicine preparation for treating fractures and bone injuries | |
| CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
| CN102895460A (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN102441145B (en) | Medicament for treating lumbar disc herniation and cervical spondylosis | |
| CN1240425C (en) | Chinese traditional medicine for treating bone fracture and osteopathy | |
| CN101607022B (en) | Chinese medicament bone-knitting pellet preparation | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN101112482A (en) | Medicine for treating traumatic injury | |
| CN100562336C (en) | HUOXUEDAN and preparation method thereof | |
| CN100333742C (en) | Chinese materia medica preparation for curing fracture and traumatic injury | |
| CN101095883A (en) | Oral medication for treating barrenness | |
| CN101167919B (en) | Medicine composition capable of promoting the growth of bone tissue and preparation technology and application thereof | |
| CN1067571C (en) | Chinese medicine capsule for treating lumbar and cervical protrusion | |
| CN1943635B (en) | Chinese traditional medicinal preparation for treating bone injuries and osteonosus | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN101732661A (en) | Chinese medicament for treating fracture | |
| CN101284087B (en) | Medicinal composition for curing lumbar disease | |
| CN101244178A (en) | Bone-knitting ball | |
| CN100384464C (en) | Medicine for treating cerebral hemorrhage | |
| CN101181458B (en) | Chinese medicine preparation for curing fracture | |
| CN103157011B (en) | Traditional Chinese medicine composite for promoting fracture healing | |
| CN102631516A (en) | Medicament for treating infertility | |
| CN1284579C (en) | Oral medicine for treating ischemic necrosis of femoral head and its preparation | |
| CN115844972B (en) | Navel patch for treating osteoporosis and preparation method thereof | |
| CN101653584A (en) | Medicine for treating spondylose cervicale radiculaire |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |